Cell News and Research

RSS

Researchers study about 3-D bioprinting to make organs for transplants

Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them. In the ACS journal Langmuir, scientists are reporting new understanding about the dynamics of 3-D bioprinting that takes them a step closer to realizing their goal of making working tissues and organs on-demand.

31 Jul 2014

Researchers identify RNA that modulates action of important gene in process of programmed cell death

Researchers from the University of S-o Paulo (USP) have identified an RNA known as INXS that, although containing no instructions for the production of a protein, modulates the action of an important gene in the process of apoptosis, or programmed cell death.

31 Jul 2014

Blood-forming stem cell transplantation benefits infants with severe combined immunodeficiency

Babies who are born with severe combined immunodeficiency (SCID) can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering's Richard J. O'Reilly, MD, a world-renowned pioneer in the development of transplant protocols.

31 Jul 2014

No two single tumor cells in breast cancer patients have same genome

Just as no two people possess the same genetic makeup, a recent study has shown that no two single tumor cells in breast cancer patients have an identical genome.

31 Jul 2014

Nearly 1 in every 20 elderly American adults faces financial exploitation

Nearly one in every twenty elderly American adults is being financially exploited - often by their own family members. This burgeoning public health crisis especially affects poor and black people. It merits the scrutiny of clinicians, policy makers, researchers, and any citizen who cares about the dignity and well-being of older Americans, says Dr. Janey Peterson of Weill Cornell Medical College in the US.

31 Jul 2014

Post-doctoral fellows working on stem cell treatment for stroke

The San Antonio Life Sciences Institute, a joint venture between The University of Texas at San Antonio and The University of Texas Health Science Center at San Antonio, has selected the winners of the Postdoc Initiative Pilot Program.

31 Jul 2014

Discovery could lead to development of new cancer therapies

DNA mutations-long known to fuel cancer as well as evolutionary changes in a living organism-had been thought to be rare events that occur randomly throughout the genome.

31 Jul 2014

Researchers discover new function of body's most important tumor-suppressing protein

Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a new function of the body's most important tumor-suppressing protein. Called p53, this protein has been called "the guardian of the genome."

30 Jul 2014

Researchers develop vaccine against potentially deadly tick-transmitted disease

Virginia Commonwealth University School of Medicine researchers have made an important advancement toward developing a vaccine against the debilitating and potentially deadly tick-transmitted disease, human granulocytic anaplasmosis (HGA).

30 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

Scientists show for the first time how structures inside cells are regulated

New research from scientists at the University of Kent has shown for the first time how the structures inside cells are regulated - a breakthrough that could have a major impact on cancer therapy development.

30 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

New stem-cell discovery may lead to more streamlined process for tissue regeneration

A new stem-cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts, according to UC San Francisco scientists who reported the findings in the current edition of Cell.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Cell News and Research

Researchers study about 3-D bioprinting to make organs for transplants

Researchers identify RNA that modulates action of important gene in process of programmed cell death

Blood-forming stem cell transplantation benefits infants with severe combined immunodeficiency

No two single tumor cells in breast cancer patients have same genome

Nearly 1 in every 20 elderly American adults faces financial exploitation

Post-doctoral fellows working on stem cell treatment for stroke

Discovery could lead to development of new cancer therapies

Researchers discover new function of body's most important tumor-suppressing protein

Researchers develop vaccine against potentially deadly tick-transmitted disease

Researchers establish new strategy to help surgeons see entire tumor in patient

Scientists show for the first time how structures inside cells are regulated

EMD Serono begins MSB0010718C Phase II study in mMCC patients

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

New stem-cell discovery may lead to more streamlined process for tissue regeneration

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Biochemists report advance in production of functional mirror-image proteins

Little-known supportive cells in brain may play major role in cognitive function

Study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress

3 letters can help drivers to take proper safety precautions when traveling in car with kids

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring